BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 111380
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111380
Table 4 Antibiotic resistances of Helicobacter pylori treatment-naive patients across different regions in Taiwan

Region
Patient number
Proportion, % (95%CI)
P value (χ2 test for linear trend)
AmoxicillinSouth11/8181.3 (0.6-2.2)0.606
North5/5011.0 (0.2-1.9)
East2/892.2 (0.0-5.8)
ClarithromycinSouth144/81817.6 (15.0-12.2)0.360
North88/50117.6 (14.2-20.9)
East21/8923.6 (14.6-32.6)
MetronidazoleSouth248/81830.3 (27.2-33.5)0.784
North160/50131.9 (27.8-36.0)
East29/8932.6 (22.7-42.5)
TetracyclineSouth8/8181.0 (0.3-1.7)0.080
North1/5010.2 (0.0-0.6)
East2/892.2 (0.0-5.8)
LevofloxacinSouth253/81830.9 (27.8-34.1)0.044
North133/50126.5 (22.7-30.4)
East18/8920.2 (11.7-28.7)


Write to the Help Desk